Relay Therapeutics annual meeting; executive compensation advisory vote passes with 60% support

Relay Therapeutics, Inc.

Stockholders elected Sanjiv K. Patel (109.9M for) and Linda A. Hill (91.3M for) as class I directors.
Non-binding advisory vote on executive compensation passed: 66.7M for, 44.7M against (40% opposed).
Ratification of Ernst & Young as auditor for FY2024 approved with 119.4 million votes for.
Broker non-votes totaled 8.2M on director election and advisory compensation proposals.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.